metaPreg - Clorazepate during pregnancy

Clorazepate updated on 02-10-2025

Table Graphic exposition period:

Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
Congenital malformations
Limb reduction defects (LRD)	2.64 [1.13, 6.16]	-	1 study	548		not evaluable	ROB	4.72 [1.52; .]
Intrauterine deaths
Adverse outcome	OR 95%CI	I2	k	No. cases	No. exposed	publication bias	ROB	E-value
1 non statistically significant endpoints reported in only one study